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Abstract
Introduction: To review published studies related to the as-
sociation of severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2) infections with pregnancy, foetal, and neo-
natal outcomes during coronavirus disease 2019 (COVID-19) 
pandemic in a systematic manner. Methods: A comprehen-
sive electronic search was done through PubMed, Scopus, 
Medline, Cochrane database, and Google Scholar from De-
cember 01, 2019, to May 22, 2020, along with the reference 
list of all included studies. All cohort studies that reported on 
outcomes of COVID-19 during pregnancy were included. 
Qualitative assessment of included studies was performed 
using the Newcastle-Ottawa scale. Results: Upon admission, 
most pregnant women underwent a low-dose radiation CT 
scan; the reports of which included unilateral/bilateral pneu-
monia in most patients. A marked lymphopenia was also 
noted in many patients with COVID-19. 513 titles were 
screened, and 22 studies were included, which identified 
156 pregnant women with COVID-19 and 108 neonatal out-
comes. The most common maternal/foetal complications in-
cluded intrauterine/foetal distress (14%) and premature rup-
ture of membranes (8%). The neonatal clinical manifesta-
tions of COVID-19 commonly included shortness of breath 
(6%), gastrointestinal symptoms (4%), and fever (3%). Con-
clusion: COVID-19 infection in pregnancy leads to increased 
risk in pregnancy complications such as preterm birth, 
PPROM, and may possibly lead to maternal death in rare cas-
es. There is no evidence to support vertical transmission of 
SARS-CoV-2 infection to the unborn child. Due to a paucity 
of inconsistent data regarding the impact of COVID-19 on 
the newborn, caution should be undertaken to further inves-
tigate and monitor possible infection in the neonates born 
to COVID-19-infected mothers. © 2020 S. Karger AG, Basel
Introduction
The current coronavirus disease 2019 (COVID-19) 
pneumonia pandemic, caused by the severe acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2), has become 
a major global health threat. Since its first identification 
in Wuhan, China, in December 2019, COVID-19 has 
spread globally at an accelerated rate with rapid increases 
in cases and mortality [1, 2].
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Viral pneumonia is one of the leading causes of preg-
nancy deaths worldwide [3]. Physiological changes dur-
ing pregnancy, such as reduced functional residual vol-
umes, diaphragm elevation, and oedema of respiratory 
tract mucosa, as well as changes in cell immunity can 
lead to increased susceptibility to viral infections and 
can have worsened outcomes [4]. However, to date, 
there are limited studies pertaining to the outcomes of 
COVID-19 during pregnancy, differences in clinical 
course, and the potential risks to the unborn child. Stud-
ies have so far shown that the clinical, radiological, and 
laboratory characteristics of COVID-19 pneumonia in 
pregnant women are similar to those reported for non-
pregnant patients [5–10]. Moreover, currently there has 
been no evidence of intrauterine vertical transmission of 




This study was done according to Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) method 
identifying published literature on COVID-19 and its potential 
impact on pregnancy and neonates. The comprehensive literature 
search was carried out with PubMed, Medline, Scopus, Cochrane 
database, and Google Scholar, using key MeSH words, which in-
clude “COVID-19,” “Pregnancy,” “Coronavirus 2019,” “New-
born,” “Foetus,” “Neonate,” “vertical transmission,” and “out-
comes.” All published articles have been reviewed, and the find-
ings have been included in this study. The relevant articles have 
been cited and referenced within this study. The limits included 
studies in English and articles published after December 2019 un-
til May 22, 2020. All the relevant articles identified were analysed 
by 2 authors, and the results were appropriately summarised and 
reported.
Inclusion and Exclusion Criteria
The key inclusion criteria were articles that reported on out-
comes of COVID-19 during pregnancy, and studies were excluded 
if no cohort outcomes were observed. Other exclusion criteria 
were consensus documents, editorials, commentaries, and narra-
tive reviews.
Table 1. Newcastle-Ottawa scale table










that outcome of 
interest was present  
at start of study
Reporting of 
pregnant 










Liu et al. [4] * * * * ** * * *
Chen et al. [5] * * * * ** * * *
Zhu et al. [6] * * * * ** * * *
Liu et al. [7] * * * * ** * *
Wang et al. [12] * * * * ** * * *
Liu et al. [13] * * * * ** * *
Yu et al. [14] * * * * ** * * *
Li et al. [15] * * * * ** * * *
Fan et al. [16] * * * * ** * * *
Wang et al. [17] * * * * ** * * *
Zambrano et al. [18] * * * * ** * * *
Iqbal et al. [19] * * * * ** * * *
Lee et al. [20] * * * * ** * * *
Liu et al. [21] * * * * * *
Karami et al. [22] * * * * ** * * *
Hantoushzadeh et al. [29] * * * * ** * * *
Baud et al. [30] * * * * ** * * *
Shanes et al. [31] * * * * * * *
Penfield et al. [33] * * * * * * *
Gidlöf et al. [34] * * * * ** * * *
Chen et al. [35] * * * * ** * * *
Breslin et al. [36] * * * * ** *
COVID-19, coronavirus disease 2019.
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Data Extraction
All studies were screened by 2 authors independently (H.A. and 
C.P.); disagreement was resolved by consensus or involvement of 
other authors (E.A. and A.H.). The extracted data then were cross-
checked by a third author to validate their accuracy (E.A.).
Methodological Quality Assessment of Included Studies
Qualitative assessment of included studies was performed us-
ing the Newcastle-Ottawa scale [11] (Table 1). The Newcastle-Ot-
tawa scale was devised specifically to assess the quality of non-
randomised studies included in systematic reviews and meta-anal-
yses. It assesses bias of each study using a star-based rating system, 
with a maximum score of 9 indicating lowest risk of bias and a 
minimum of 0 indicating highest risk. Scores ≥7 generally repre-
sent a low risk of substantial bias. Quality of included studies was 
rated by 2 reviewers (H.A. and C.P.). Discrepancies were resolved 
by consensus.
Statistical Analysis
It was not possible to do pooled analysis due to lack of consis-
tent data within the current reported studies.
Results
Following an extensive database search, a total of 670 
were found initially, and after full text screening, only 22 
studies met the inclusion criteria [4–7, 12–25] (Fig. 1), 
identifying 156 pregnant women with COVID-19 and 
108 neonatal outcomes. Table 2 includes the summarised 
key findings of the studies included in this review.
Analysis of the Reports
A total of 156 pregnant women with COVID-19 have 
been identified and 108 newborns (including 4 sets of 
twins and 10 foetal deaths) have been included in this re-
view. The maternal ages ranged from 22 to 42 years. Sixty-
six caesarean sections and 19 normal vaginal deliveries 
were identified. The remaining included pregnant wom-
en who have not yet given birth and unrecorded data in 
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Records identified through database search of: COVID-19, Pregnancy, Foetus,
SARS-CoV-2, vertical transmission, pregnant woman, preterm delivery
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Most of the mothers received nasal oxygen therapy; 
however, 11 patients were reported to receive intubation 
and mechanical ventilation. Many of the pregnant women 
received antiviral and antibiotic medications.  A study by 
Yu et al. [14] reported the use of traditional Chinese med-
ications in all 7 of their patients. Maternal clinical mani-
festations reported were fever (53%), cough (32%), fa-
tigue/malaise (13%), myalgia (11%), sore throat (5%), and 
shortness of breath (8%). Upon admission, most pregnant 
women underwent a low-dose radiation CT scan; the re-
ports of which included unilateral/bilateral pneumonia in 
most patients. A marked lymphopenia was also noted in 
many patients with COVID-19. The most common ma-
ternal/foetal complications included intrauterine/foetal 
distress (14%) and premature rupture of membranes 
(PROM) (8%). The neonatal clinical manifestations of 
COVID-19 commonly included shortness of breath (6%), 
gastrointestinal symptoms (4%), and fever (3%).
Discussion
Impact of COVID-19 on Pregnancy
The health of pregnant women needs to be taken into 
account during this rapidly changing coronavirus pan-
demic. It is important to provide critical interventions 
necessary for pregnant women. These carefully evaluated 
decisions must be extensively discussed while consider-
ing both maternal and foetal outcomes in the context of 
the potential impact of COVID-19 on the pregnancy.
World Health Organisation (WHO) has reported that 
there is no apparent difference in the risk of developing 
clinical symptoms between non-pregnant and pregnant 
women of reproductive age [5, 26]. It seems the latter is 
also not at a higher risk of developing severe disease. Pa-
tients most commonly present with mild symptoms of 
the infection including fever, cough, fatigue, and short-
ness of breath; however, some may be asymptomatic [4–
7, 12–20]. In a retrospective review by Liu et al. [21], a 
comparison of 59 patients, which included both pregnant 
and non-pregnant adults, was carried out. This review re-
ported no significant difference between the various 
groups regarding the development of the clinical features 
of SARS-CoV-2.
Pregnant women undergo physiological changes, 
which lead to altered immune systems [27]. This does not 
necessarily make them more susceptible to viral infection; 
hence, their response to COVID-19 may be similar to any 
other viral infection. However, due to the modulated im-
mune system, they may experience severe symptoms, al-
beit there is a low probability of this happening. Accord-
ing to 1 study, pregnancy itself does not worsen the symp-
toms experienced, nor the findings on a CT scan of 
COVID-19 related pneumonia [4].
Given the novelty of COVID-19, not enough evidence 
is available to conclude the definite effect of this virus 
during pregnancy. Comparison to other coronavirus in-
fections, such as SARS and MERS, may provide a possible 
indication of the outcome of the COVID-19 virus process 
[22, 28]. Three studies have reported no maternal com-
plications, such as postpartum COVID-19 infection and 
preterm labour [5, 12, 14]. However, various other studies 
have reported both maternal and foetal complications in-
cluding preterm delivery, respiratory distress, foetal dis-
tress, and PROM [6]. Additionally, a case report pub-
lished in Iran has stated 1 maternal death and subse-
quently 1 intrauterine foetal death, which has been 
directly linked to the COVID-19 infection during the 
third trimester [22]. In an adjudicated case series from 
Iran, 9 pregnant women diagnosed with severe COV-
ID-19 disease during their later second or third trimester 
were identified. At the time of reporting, 7 of 9 died, 1 of 
9 remained critically ill and ventilator-dependent, and 1 
of 9 recovered after prolonged hospitalisation [29]. More-
over, Baud et al. [30] reported a case of miscarriage during 
the second trimester of pregnancy in a woman with CO-
VID-19, which appeared to be related to placental infec-
tion with SARS-CoV-2.
Shanes et al. [31] examined the placentas of 16 women 
with severe COVID-19 infection (15 live births in the 
third trimester and 1 delivered in the second trimester 
after intrauterine foetal demise). The study found that 
pregnant women who were infected with COVID-19 and 
delivered in the third trimester were more likely to have 
placentas that show features of maternal vascular malp-
erfusion and intervillous thrombi. No pathognomonic 
features were identified; however, these findings suggest 
abnormal maternal circulation that is associated with ad-
verse perinatal outcomes. These changes may reflect a 
systemic inflammatory or hypercoagulable state influ-
encing placental physiology. Shanes et al. [31] notes that 
increased antenatal surveillance for women with CO-
VID-19 may be warranted.
According to the Royal College of Obstetricians and 
Gynaecologists (RCOG), vertical transmission from the 
woman to her baby may be possible, as suggested by new 
evidence [27]. A few emerging studies have reported the 
probability of in utero COVID-19 transmission by mea-
suring the foetal IgM blood level [16, 23, 32]. The IgM 
antibody is not transferred via the placenta; therefore, it 
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is suggested that this may possibly be the foetal immune 
response to the infection. One study reported COVID-19 
infection in a neonate 36 h after birth [14]. Further tests 
looking into the probability of intrauterine transmission 
concluded negative results for SARS-CoV-2 nucleic acid 
test of the placenta and cord blood in that particular pa-
tient. This is further supported by earlier case reports 
from China, which have provided evidence that suggests 
no correlation of vertical transmission. These reports 
have also mentioned negative COVID-19 results of sam-
ples obtained from the infected women’s amniotic fluid, 
cord blood, genital swabs, and breast milk, and the neo-
natal throat swabs; therefore, all the neonates have tested 
negative so far [5, 6, 24, 25]. However, Penfield et al. [33] 
have reported a study in which of 11 placental or mem-
brane swabs sent following delivery, 3 swabs were positive 
for SARS-CoV-2, all in women with moderate to severe 
COVID-19 illness at time of delivery. This is the first 
study to demonstrate the presence of SARS-CoV-2 RNA 
in placental or membrane samples. Whilst there were no 
clinical signs of vertical transmission, their findings raise 
the possibility of intrapartum viral exposure. Therefore, 
caesarean deliveries would be the recommended mode of 
delivery to decrease length of exposure to these tissues 
and thus decrease likelihood of possible vertical transmis-
sion. Taking all available evidence into consideration, 
there are only a small number of reported cases to con-
clude whether there is an intrauterine vertical transmis-
sion of SARS-CoV-2. Therefore, stating any definitive 
outcome is not possible at this point in time. Data collec-
tion from MBRRACE-UK has recently been established 
for which monitoring of affected women and their new-
borns is being carried out [27]. This will hopefully pro-
vide useful data collection and help support outcomes for 
future reports. Furthermore, a larger case series is needed 
to define the relationship between SARS-CoV-2, acute in-
flammation, and intrauterine foetal demise.
Impact of COVID-19 on the Foetus
According to RCOG, there is currently not enough 
data to provide a correlation between the risk of miscar-
riage and COVID-19 or that the virus is teratogenic [27]. 
The possibility of vertical transmission needs further re-
search as there have been conflicting results so far. Foetal 
outcomes, where there is evidence of maternal COVID-19 
infection, have been reported to include foetal and respi-
ratory distress in utero, PROM, and premature delivery 
[4–7, 13, 15, 18, 22]. However, whether the preterm deliv-
ery is due to iatrogenic aetiology or other causes, it needs 
to be further investigated for a definitive answer [27].
Impact of COVID-19 on the Newborn
Many studies reported asymptomatic newborns, 
born to mothers with COVID-19 infection. One study 
by Zhu et al. [6] has reported neonatal COVID-19 symp-
toms to include shortness of breath, fever, and gastroin-
testinal symptoms such as vomiting and abdominal dis-
tension. Study by Fan et al. [16] also reported similar 
symptoms.
There have been promising results shown across 
many studies in this systematic review regarding neona-
tal outcomes [5, 6, 13]. Most of the symptoms experi-
enced by the neonates were regularly monitored and 
managed with conservative treatment from which the 
babies recovered well. A study by Yu et al. [14] reported 
7 pregnant women positive for SARS-CoV-2. Following 
their caesarean sections, the infants suspected of a pos-
sible COVID-19 infection were also tested. Only 1 neo-
nate was identified as positive at 36 h after birth, with 
mild shortness of breath symptoms. Following this, the 
infant recovered well and was subsequently discharged 
from hospital.
Some studies have reported unfavourable neonatal 
outcomes. It is important to consider blood test results 
in conjunction with SARS-CoV-2 nucleic acid test due 
to the higher false-negative rate in the latter and the as-
ymptomatic presentation of many neonates [6]. Zhu et 
al. [6] described 10 neonates that tested negative for 
SARS-CoV-2. However, 2 neonates had thrombocyto-
penia and abnormal liver function tests; following which 
1 neonate fully recovered, but 1 neonate died. The death 
of the neonate is assumed to have been precipitated by 
various different factors including poor immune func-
tion, refractory shock due to major viraemia, multiple 
organ failure, and disseminated intravascular coagula-
tion. Therefore, it was concluded that false negatives of 
the SARS-CoV-2 nucleic acid test could not be ruled out. 
Fan et al. [16] have reported lymphopenia and mild 
pneumonia findings in 2 neonates, with no significant 
clinical features, born to infected mothers. This was fur-
ther supported by Wang et al. [17], who reported de-
ranged liver function tests and lymphopenia in an as-
ymptomatic neonate born to SARS-CoV-2 infected 
mother. Neonatal deaths have been reported by Karami 
et al. [22] and Liu et al. [7], where unfavourable preg-
nancy characteristics including maternal multiple organ 
dysfunction syndrome are thought to be associated with 
the poor neonatal outcomes. Therefore, caution should 
be undertaken to further investigate and monitor pos-
sible infection in the neonates born to COVID-19-in-
fected mothers.
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Future Studies
The potential transmission of COVID-19 through 
breast milk is unknown. Large studies are needed to deter-
mine whether COVID-19 can be transmitted to newborns 
through breast milk from their infected mother. Current-
ly, no data have supported that SARS-CoV-2 could be 
transmitted through breast milk. Chen et al. [5] tested for 
SARS-CoV-2 in breast milk samples from 6 infected pa-
tients, and all samples tested negative for the virus. There-
fore, while this suggests that human milk does not act as a 
vehicle for COVID-19, further studies with larger sample 
sizes are recommended. Future studies should also assess 
whether there is a risk of ascending infection during la-
bour by testing for SARS-COV-2 in intrapartum vaginal 
secretion samples, placental tissue, and amniotic fluid and 
amnion-chorion interface swap samples.
Longitudinal studies and clinical analysis are needed 
to assess the clinical course of infants born to infected 
mothers. Furthermore, maternal inflammation in re-
sponse to SARS-COV-2 infection could have adverse ef-
fects on the developing foetus [37]. More studies in this 
area are recommended [38–40].
Conclusion
Given the novelty of COVID-19, data on the effect of 
COVID-19 on pregnancy, the foetus, and the newborn 
are so far limited to a few small case series. Nevertheless, 
while pregnant women do better than the population 
aged 80 years and above, they have twice the higher rate 
of PPROM and 3 times the higher rate of preterm births 
compared to the general pregnant population. There is 
not enough evidence to support vertical transmission of 
SARS-CoV-2 infection to the unborn child. Due to a pau-
city of inconsistent data regarding the impact of CO-
VID-19 on the newborn, caution should be undertaken 
to further investigate and monitor possible infection in 
the neonates born to COVID-19-infected mothers.
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